John Ransom
Stock Analyst at Raymond James
(4.62)
# 196
Out of 4,962 analysts
218
Total ratings
66.15%
Success rate
15.59%
Average return
Main Sectors:
Stocks Rated by John Ransom
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ACHC Acadia Healthcare Company | Downgrades: Outperform | $40 → $26 | $22.05 | +17.91% | 9 | Aug 14, 2025 | |
RDNT RadNet | Reiterates: Strong Buy | $66 → $75 | $69.64 | +7.70% | 12 | Aug 13, 2025 | |
AVAH Aveanna Healthcare Holdings | Upgrades: Outperform | $9 | $7.61 | +18.27% | 8 | Aug 11, 2025 | |
SCI Service Corporation International | Reiterates: Outperform | $85 → $90 | $79.85 | +12.71% | 13 | Aug 4, 2025 | |
THC Tenet Healthcare | Reiterates: Outperform | $185 → $200 | $179.75 | +11.27% | 18 | Jul 23, 2025 | |
CI The Cigna Group | Maintains: Strong Buy | $360 → $385 | $299.84 | +28.40% | 18 | May 5, 2025 | |
UNH UnitedHealth Group | Reiterates: Strong Buy | $635 → $540 | $304.93 | +77.09% | 13 | Apr 21, 2025 | |
HCA HCA Healthcare | Downgrades: Market Perform | n/a | $402.54 | - | 21 | Nov 22, 2024 | |
CYH Community Health Systems | Downgrades: Underperform | n/a | $2.72 | - | 8 | Nov 22, 2024 | |
GDRX GoodRx Holdings | Upgrades: Outperform | $10 | $4.29 | +133.10% | 2 | May 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Strong Buy | $85 → $95 | $122.38 | -22.37% | 15 | Apr 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | n/a | $11.96 | - | 7 | Mar 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $298.42 | - | 1 | Mar 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $16.69 | +19.83% | 1 | Mar 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $25 → $30 | $29.52 | +1.63% | 12 | Mar 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $10 → $12 | $15.87 | -24.39% | 9 | Jan 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $70.93 | +19.84% | 7 | Aug 4, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $105 | $117.23 | -10.43% | 8 | Aug 2, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $10 | $6.45 | +55.04% | 4 | Aug 1, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $3.28 | - | 11 | May 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $25.52 | - | 7 | May 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $46.65 | - | 2 | Feb 14, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $27.70 | - | 2 | Dec 20, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $138.00 | - | 8 | Nov 7, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $23.09 | - | 2 | Aug 9, 2017 |
Acadia Healthcare Company
Aug 14, 2025
Downgrades: Outperform
Price Target: $40 → $26
Current: $22.05
Upside: +17.91%
RadNet
Aug 13, 2025
Reiterates: Strong Buy
Price Target: $66 → $75
Current: $69.64
Upside: +7.70%
Aveanna Healthcare Holdings
Aug 11, 2025
Upgrades: Outperform
Price Target: $9
Current: $7.61
Upside: +18.27%
Service Corporation International
Aug 4, 2025
Reiterates: Outperform
Price Target: $85 → $90
Current: $79.85
Upside: +12.71%
Tenet Healthcare
Jul 23, 2025
Reiterates: Outperform
Price Target: $185 → $200
Current: $179.75
Upside: +11.27%
The Cigna Group
May 5, 2025
Maintains: Strong Buy
Price Target: $360 → $385
Current: $299.84
Upside: +28.40%
UnitedHealth Group
Apr 21, 2025
Reiterates: Strong Buy
Price Target: $635 → $540
Current: $304.93
Upside: +77.09%
HCA Healthcare
Nov 22, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $402.54
Upside: -
Community Health Systems
Nov 22, 2024
Downgrades: Underperform
Price Target: n/a
Current: $2.72
Upside: -
GoodRx Holdings
May 16, 2024
Upgrades: Outperform
Price Target: $10
Current: $4.29
Upside: +133.10%
Apr 26, 2024
Reiterates: Strong Buy
Price Target: $85 → $95
Current: $122.38
Upside: -22.37%
Mar 26, 2024
Maintains: Market Perform
Price Target: n/a
Current: $11.96
Upside: -
Mar 22, 2024
Initiates: Market Perform
Price Target: n/a
Current: $298.42
Upside: -
Mar 22, 2024
Initiates: Outperform
Price Target: $20
Current: $16.69
Upside: +19.83%
Mar 15, 2024
Reiterates: Outperform
Price Target: $25 → $30
Current: $29.52
Upside: +1.63%
Jan 9, 2024
Maintains: Strong Buy
Price Target: $10 → $12
Current: $15.87
Upside: -24.39%
Aug 4, 2023
Maintains: Outperform
Price Target: $90 → $85
Current: $70.93
Upside: +19.84%
Aug 2, 2023
Maintains: Outperform
Price Target: $100 → $105
Current: $117.23
Upside: -10.43%
Aug 1, 2023
Maintains: Outperform
Price Target: $8 → $10
Current: $6.45
Upside: +55.04%
May 10, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $3.28
Upside: -
May 3, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $25.52
Upside: -
Feb 14, 2020
Downgrades: Market Perform
Price Target: n/a
Current: $46.65
Upside: -
Dec 20, 2019
Initiates: Market Perform
Price Target: n/a
Current: $27.70
Upside: -
Nov 7, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $138.00
Upside: -
Aug 9, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $23.09
Upside: -